ScoreComparison
Why is Immuno-Biological Laboratories Co., Ltd. ?
1
Poor Management Efficiency with a low ROE of 6.24%
- The company has been able to generate a Return on Equity (avg) of 6.24% signifying low profitability per unit of shareholders funds
2
Healthy long term growth as Operating profit has grown by an annual rate 18.65%
3
With a growth in Net Profit of 32.11%, the company declared Very Positive results in Dec 25
- NET PROFIT(HY) At JPY 187.08 MM has Grown at 128.22%
- NET SALES(HY) At JPY 530.7 MM has Grown at 17.8%
- RAW MATERIAL COST(Y) Fallen by -9.55% (YoY)
4
With ROE of 16.42%, it has a attractive valuation with a 3.16 Price to Book Value
- Over the past year, while the stock has generated a return of 186.49%, its profits have risen by 32.9% ; the PEG ratio of the company is 0.6
5
Market Beating Performance
- The stock has generated a return of 186.49% in the last 1 year, much higher than market (Japan Nikkei 225) returns of 38.94%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Immuno-Biological Laboratories Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Immuno-Biological Laboratories Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Immuno-Biological Laboratories Co., Ltd.
186.49%
1.61
110.82%
Japan Nikkei 225
38.94%
1.38
28.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
10.95%
EBIT Growth (5y)
18.65%
EBIT to Interest (avg)
-8.88
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.41
Sales to Capital Employed (avg)
0.58
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.25%
ROE (avg)
6.24%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
3.16
EV to EBIT
19.86
EV to EBITDA
18.49
EV to Capital Employed
4.66
EV to Sales
4.29
PEG Ratio
0.58
Dividend Yield
NA
ROCE (Latest)
23.45%
ROE (Latest)
16.42%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
NET PROFIT(HY)
At JPY 187.08 MM has Grown at 128.22%
NET SALES(HY)
At JPY 530.7 MM has Grown at 17.8%
RAW MATERIAL COST(Y)
Fallen by -9.55% (YoY
CASH AND EQV(HY)
Highest at JPY 1,848.62 MM
-3What is not working for the Company
INTEREST(9M)
At JPY 1.02 MM has Grown at 8.07%
INVENTORY TURNOVER RATIO(HY)
Lowest at 0.86 times
Here's what is working for Immuno-Biological Laboratories Co., Ltd.
Net Profit
At JPY 187.08 MM has Grown at 128.22%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (JPY MM)
Net Sales
At JPY 530.7 MM has Grown at 17.8%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (JPY MM)
Cash and Eqv
Highest at JPY 1,848.62 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -9.55% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Immuno-Biological Laboratories Co., Ltd.
Interest
At JPY 1.02 MM has Grown at 8.07%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Inventory Turnover Ratio
Lowest at 0.86 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
